跳至主要内容
临床试验/NCT04051294
NCT04051294已完成不适用

A Clinical Trial to Measure the Biochemical Response of Kombucha Tea in Humans

University of Missouri-Columbia2 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2019年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
2
主要终点
Fasting insulin level.

研究概览

简要总结

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.

详细描述

Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp & Sumner, 2019) revealed a lack of evidence for human health benefit. Despite the lack of evidence, U.S. retail sales of kombucha and other fermented beverages have increased 37.4% in 2017, and kombucha is the fastest growing product in the functional beverage market.

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans. We plan for 20 subjects to take part in this study.

This is a randomized-controlled counter-balanced study design. Subjects will be asked to complete 4 in-person visits over 2 months time (twice per month). At the first visit, subjects will be randomized into one of four groups. At each subsequent visit, subjects will be randomized into one of the remaining groups until they have completed each arm.

Arms (at least 5 subjects in each arm, minimum total=20 subjects)

  1. Intervention group 1: commercial kombucha: drink 8oz kombucha
  2. Intervention group 2: brewed kombucha: drink 8oz kombucha
  3. Control group: drink 8oz tea (the same type as used to brew the kombucha)
  4. Control group 2: drink 8oz tap water

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women ages 30-65 years old
  • English-speaking
  • Have transportation to campus
  • Overweight (BMI >= 25 kg/m2) or obese (BMI >=30 kg/m2)

排除标准

  • Currently use any type of nicotine product
  • A diagnosis of any of the following:
  • Diabetes (type 1 or 2)
  • Chronic alcoholism
  • Peripheral vascular disease
  • Autoimmune disease
  • Chronic kidney disease
  • Pregnant or breastfeeding
  • Prescribed medication for insulin, glucose-lowering drugs, or steroids, such as prednisone
  • Have routinely taken prebiotic or probiotic supplements in the past 3 months
  • Have routinely consumed any of the following more than one time per week in the past month: kombucha, kefir, yogurt, kimchi, cottage cheese, raw apple cider vinegar (with the "mother"), sauerkraut, kvass.

结局指标

主要结局

Fasting insulin level.

时间窗: Baseline

Blood drawn following a 10-12 hour fast.

Blood glucose level

时间窗: 3 hour

Oral glucose tolerance test

Fasting blood glucose level

时间窗: Baseline

Blood drawn following a 10-12 hour fast.

Insulin level

时间窗: 3 hour

Oral glucose tolerance test

次要结局

  • Blood pressure(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie Kapp

Associate Professor

University of Missouri-Columbia

研究点 (2)

Loading locations...

相似试验